Lv3
352 积分 2023-11-06 加入
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial
9天前
已完结
Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
15天前
已完结
Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases
15天前
已完结
Wistar and Sprague–Dawley rats
15天前
已完结
Safety, pharmacokinetics and pharmacodynamics of HWH486 capsules in healthy adults: A randomized, double-blind, placebo-controlled, phase I dose-escalation study
1个月前
已完结
Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis
1个月前
已完结
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
1个月前
已完结
Isolation and characterization of IgG1 with asymmetrical Fc glycosylation
1个月前
已完结
Depletion of mast cells with barzolvolimab, an anti‐KIT antibody, does not affect mast cell progenitors
1个月前
已完结
Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
1个月前
已完结
皖公网安备34019202002308
